Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to porphyromonas gingivalis

Journal of Periodontology

Volumn 84, Issue 9, 2013, Pages 1337-1345

  Berker, Ezel ^a,b   Kantarci, Alpdogan ^b   Hasturk, Hatice ^b   Van Dyke, Thomas E ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b FORSYTH INSTITUTE   (United States)

Author keywords

Interleukin 10; Interleukin 4; Monocytes; Periodontitis; Porphyromonas gingivalis

Indexed keywords

AUTACOID; CONCANAVALIN A; CYTOKINE; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL CULTURE; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CULTURE TECHNIQUE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MICROBIOLOGY; MONOCYTE; MONONUCLEAR CELL; PHAGOCYTE; PORPHYROMONAS GINGIVALIS;

ADULT; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHRONIC PERIODONTITIS; CONCANAVALIN A; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MONOCYTES; PHAGOCYTES; PORPHYROMONAS GINGIVALIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883421431     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120422     Document Type: Article

References (44)

1. Grenier D, La VD. Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: A review article. Curr Drug Targets 2011;12: 322-331.
2. Lin L, Li C, Liu J, et al. Virulence genes of Porphyromonas gingivalis W83 in chronic periodontitis. Acta Odontol Scand 2009;67:258-264.
3. Pollreisz A, Huang Y, Roth GA, et al. Enhanced monocyte migration and pro-inflammatory cytokine production by Porphyromonas gingivalis infection. J Periodontal Res 2010;45:239-245.
4. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med 2002;13:132-142.
5. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14: 33-53.
6. Bostanci N, Allaker RP, Belibasakis GN, et al. Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 2007;39:147-156.
7. Teng YT. Protective and destructive immunity in the periodontium: Part 1 - Innate and humoral immunity and the periodontium. J Dent Res 2006;85:198-208.
8. Gemmell E, Carter CL, Grieco DA, Sugerman PB, Seymour GJ. P. gingivalis-specific T-cell lines produce Th1 and Th2 cytokines. J Dent Res 2002;81: 303-307.
9. Pradeep AR, Roopa Y, Swati PP. Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease. J Periodontal Res 2008;43:712-716.
10. Zaric S, Shelburne C, Darveau R, et al. Impaired immune tolerance to Porphyromonas gingivalis lipopolysaccharide promotes neutrophil migration and decreased apoptosis. Infect Immun 2010;78: 4151-4156.
11. Mossman TR, Cherwinski H, Bond MV, Giedlen MA, Coffman RL. Two types of helper T cells clones. J Immunol 1986;136:2348-2356.
12. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-1172.
13. Fujihashi K, Beagley KW, Kono Y, et al. Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. Am J Pathol 1993;142:1239-1250.
14. Aoyagi T, Sugawara-Aoyagi M, Yamazaki K, Hara K. Interleukin 4 (IL-4) and IL-6-producing memory Tcells in peripheral blood and gingival tissue in periodontitis patients with high serum antibody titers to Porphyromonas gingivalis. Oral Microbiol Immunol 1995;10:304-310.
15. Nakajima T, Yamazaki K, Cullinan MP, Gemmell E, Seymour GJ. T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch Oral Biol 1999;44:1045-1053.
16. Bozkurt FY, Berker E, Akkusx S, Bulut S. Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult periodontitis. J Periodontol 2000;71:1756-1760.
17. Walmsley M, Katsikis PD, Abney E, et al. Interleukin-10 inhibition of the progression of established collageninduced arthritis. Arthritis Rheum 1996;39:495-503.
18. Han JY, Reynolds MA. Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: A systematic review and metaanalysis. J Periodontal Implant Sci 2012;42:3-12.
19. Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: A review. J Periodontol 2005;76(Suppl. 11):2066-2074.
20. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179: 1517-1527.
21. van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JW. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-835.
22. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
23. Genco CA, Cutler CW, Kapczynski D, Maloney K, Arnold RR. A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect Immun 1991;59: 1255-1263.
24. Genco CA, Schifferle RE, Njoroge T, Forng RY, Cutler CW. Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing. Infect Immun 1995;63:393-401.
25. Westphal O, Jann K. Bacterial lipopolysaccharide. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965;5:83-91.
26. Kalmar JR, Arnold RR, Warbington ML, Gardner MK. Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J Immunol Methods 1988; 110:275-281.
27. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97:77-89.
28. Zadeh HH, Nichols FC, Miyasaki KT. The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. Periodontol 2000 1999;20:239-288.
29. Jotwani R, Cutler CW. Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response. Infect Immun 2004;72:1725-1732.
30. Suwatanapongched P, Surarit R, Srisatjaluk R, Offenbacher S. Translocation of Porphyromonas gingivalis infected monocytes and associated cellular responses. Asian Pac J Allergy Immunol 2010;28:192-199.
31. Yun PL, Decarlo AA, Collyer C, Hunter N. Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun 2001;69: 5650-5660.
32. Sugawara S, Nemoto E, Tada H, Miyake K, Imamura T, Takada H. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol 2000;165:411-418.
33. Shimauchi H, Ogawa T, Okuda K, Kusumoto Y, Okada H. Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes. Infect Immun 1999;67:2153-2159.
34. Hamedi M, Belibasakis GN, Cruchley AT, Rangarajan M, Curtis MA, Bostanci N. Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. Cytokine 2009;45:99-104.
35. Kinane DF, Lappin DF. Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand 2001;59:154-160.
36. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: Inversion of a paradigm. Ann Periodontol 1998;3:108-120.
37. Paul WE. Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 1991;77:1859-1870.
38. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
39. Champaiboon C, Yongvanitchit K, Pichyangkul S, Mahanonda R. The immune modulation of B-cell responses by Porphyromonas ginginvalis and interleukin-10. J Periodontol 2000;71:468-475.
40. Yamamato M, Fujihashi K, Hiroi T, et al. Molecular and cellular mechanisms for periodontal disease: Role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J Periodontal Res 1997;32:115-119.
41. Rudney JD, Chen R, Sedgewick GJ. Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun 2001;69:2700-2707.
42. Tam V, O'Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B, Reynolds EC. The RgpA-Kgp proteinaseadhesin complexes of Porphyromonas gingivalis inactivate the Th2 cytokines interleukin-4 and interleukin-5. Infect Immun 2009;77:1451-1458.
43. Marcelletti JF. IL-10 inhibits lipopolysaccharideinduced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response. J Immunol 1996;157:3323-3333.
44. Miossec P,NaviliatM,D'AngeacAD,Sany J, Banchereau J. Low levels of IL-4 and high levels of transforming growth factor b in rheumatoid synovitis. Arth Rheum 1990;33: 1180-1187.